Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press136610.17650/1994-4098-2025-21-4-45-52MAMMOLOGY. REVIEWSМАММОЛОГИЯ. ОБЗОРНЫЕ СТАТЬИReview ArticlePossibilities of breast-conserving surgery in multicentric and multifocal forms of breast cancerВозможности органосохраняющих операций при мультицентричной и мультифокальной формах рака молочной железыhttps://orcid.org/0009-0000-0450-0166VatsA. B.ВацА. Б.
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0009-0007-3112-80816144-1590LazakovichAlina A.ЛазаковичАлина Алексеевна
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0000-0001-6183-9764DashyanGarik A.ДашянГарик Альбертович
Russian Federation

Member of the RSOM Board, MD, PhD, Leading Researcher of the Department of Breast Tumors, N. N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia, Clinic of High Medical Technologies named after N. I. Pirogov

член правления РООМ, д.м.н., ведущий научный сотрудник отделения опухолей молочной железы ФГБУ «НМИЦ онкологии им. Н. Н. Петрова» Минздрава России, Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0000-0003-3348-4251AkhmedovR. M.АхмедовР. М.
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0009-0004-7511-2952ZhurovA. S.ЖуровА. С.
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0000-0001-9623-3877ShaykhelislamovaL. F.ШайхелисламоваЛ. Ф.
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comhttps://orcid.org/0000-0002-2274-8170BelousovA. M.БелоусовА. М.
Russian Federation

Clinic of High Medical Technologies named after N. I. Pirogov

Клиника высоких медицинских технологий им. Н. И. Пирогова

dr.lazakovich@gmail.comSaint Petersburg State UniversityФГБОУ ВО «Санкт-Петербургский государственный университет»20012026214455226062025Copyright ©; 2026, Vats A.B., Lazakovich A.A., Dashyan G.A., Akhmedov R.M., Zhurov A.S., Shaykhelislamova L.F., Belousov A.M.Copyright ©; 2026, Вац А.Б., Лазакович А.А., Дашян Г.А., Ахмедов Р.М., Журов А.С., Шайхелисламова Л.Ф., Белоусов А.М.2026Vats A.B., Lazakovich A.A., Dashyan G.A., Akhmedov R.M., Zhurov A.S., Shaykhelislamova L.F., Belousov A.M.Вац А.Б., Лазакович А.А., Дашян Г.А., Ахмедов Р.М., Журов А.С., Шайхелисламова Л.Ф., Белоусов А.М.https://creativecommons.org/licenses/by/4.0https://ojrs.abvpress.ru/ojrs/article/view/1366

Breast cancer still occupies a leading position among oncological diseases in women, despite the successes in its diagnosis and treatment. Multifocal and multicentric forms of breast cancer, which are characterized by the development of several tumors in one or different quadrants of the mammary gland, remain especially difficult for clinical practice. These features significantly affect the choice of treatment tactics, the scope of surgical intervention and prognosis. The article considers modern approaches to the diagnosis and treatment of multifocal and multicentric forms of breast cancer and analyzes the possibilities and limitations of breast-conserving surgery in these cases.

Рак молочной железы по-прежнему занимает ведущие позиции среди онкологических заболеваний у женщин, несмотря на успехи в его диагностике и лечении. Особенно сложными для клинической практики остаются его мультифокальная и мультицентричная формы, для которых характерно развитие нескольких опухолей в одном или разных квадрантах молочной железы. Эти особенности существенно влияют на выбор лечебной тактики, объем хирургического вмешательства и прогноз. В статье рассматриваются современные подходы к диагностике и лечению мультицентричной и мультифокальной форм рака молочной железы, а также анализируются возможности и ограничения органосохраняющих операций в этих случаях.

breast cancermulticentric breast cancermultifocal breast cancerbreast-conserving surgeryрак молочной железымультицентричный рак молочной железымультифокальный рак молочной железыорганосохраняющая операцияFeng Y., Spezia M., Huang S. et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 2018;5(2):77–106. DOI: 10.1016/j.gendis.2018.05.001Jain S., Rezo A., Shadbolt B., Dahlstrom J.E. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology 2009;41(1):57–67. DOI: 10.1080/00313020802563502Tot T., Gere M., Pekár G. et al. Breast cancer multifocality, disease extent, and survival. Hum Pathol 2011;42(11):1761–9. DOI: 10.1016/j.humpath.2011.02.002Salgado R., Aftimos P., Sotiriou C., Desmedt C. Evolving paradigms in multifocal breast cancer. Semin Cancer Biol 2015;31:111–8. DOI: 10.1016/j.semcancer.2014.07.002Garimella V., Long E.D., O’Kane S.L. et al. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer. Acta Oncol 2007;46(2):204–7. DOI: 10.1080/02841860600897884Wolters R., Wöckel A., Janni W. et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat 2013;142(3):579–90. DOI: 10.1007/s10549-013-2772-yHoussami N., Ciatto S., Macaskill P. et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26(19):3248–58. DOI: 10.1200/JCO.2007.15.2108Elshof L.E., Rutgers E.J., Deurloo E.E. et al. A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results. Breast Cancer Res Treat 2010;124(3):707–15. DOI: 10.1007/s10549-010-1064-zSkaane P., Bandos A.I., Gullien R. et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013;267(1):47–56. DOI: 10.1148/radiol.12121373Friedewald S.M., Rafferty E.A., Rose S.L. et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 2014;311(24):2499–507. DOI: 10.1001/jama.2014.6095Fallenberg E.M., Dromain C., Diekmann F. et al. Contrast-enhanced spectral mammography versus MRI: initial multicenter experience of diagnostic performance. Clin Imaging 2017;43:220–5. DOI: 10.1016/j.clinimag.2017.03.010Hruska C.B., Phillips S.W., Whaley D.H. et al. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol 2008;191(6):1805–15. DOI: 10.2214/AJR.07.3523Brem R.F., Ruda R.C., Yang J.L. et al. Breast-specific gamma-imaging for the detection of breast cancer in dense versus nondense breasts. AJR Am J Roentgenol 2016;206(2):293–8. DOI: 10.2214/AJR.15.15327Tagliafico A.S., Calabrese M., Mariscotti G. et al. Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: interim report of a prospective comparative trial. J Clin Oncol 2016;34(16):1882–8. DOI: 10.1200/JCO.2015.63.4147Mann R.M., Cho N., Moy L. Breast MRI: state of the art. Radiology 2019;292(3):520–36. DOI: 10.1148/radiol.2019182947Curigliano G., Burstein H.J., Gnant M. et al. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 [published correction appears in Ann Oncol 2025;36(3):351. DOI: 10.1016/j.annonc.2024.11.001 ]. Ann Oncol 2023;34(11):970–86. DOI: 10.1016/j.annonc.2023.08.017Chung A.P., Huynh K., Kidner T. et al. Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer. J Am Coll Surg 2012;215(1):137–47. DOI: 10.1016/j.jamcollsurg.2012.05.006Yerushalmi R., Tyldesley S., Woods R. et al. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol 2012;23(4):876–81. DOI: 10.1093/annonc/mdr326Fang M., Zhang X., Zhang H. et al. Local control of breast conservation therapy versus mastectomy in multifocal or multicentric breast cancer: a systematic review and meta-analysis. Breast Care (Basel) 2019;14(4):188–93. DOI: 10.1159/000499439Sun Y., Gao L., Zhou X. et al. Local recurrence and survival outcomes of multifocal/multicentric breast cancer after breast conserving therapy: a systematic review and meta-analysis. Clin Breast Cancer 2025;25(3):e229–39.e9. DOI: 10.1016/j.clbc.2024.10.009Rehman B., Sajjad B., Shah K. et al. Prospective randomized controlled trial evaluation safety of breast conserving surgery in multicentric/multifocal breast cancer. Breast 2023;68:S106. DOI: 10.1016/S0960-9776(23)00345-4Yu M., Xia L., Cao B. et al. A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer. Gland Surg 2023;12(2):165–82. DOI: 10.21037/gs-22-68Kobic A., Corbin K.S., Mutter R.W. et al. Long-term outcomes of breast conservation therapy in unifocal versus multifocal early stage breast cancer patients. Int J Radiat Oncol Bio Phys 2017;99(2):E24, E25.Okumura S., Mitsumori M., Yamauchi C. et al. Feasibility of breast-conserving therapy for macroscopically multiple ipsilateral breast cancer. Int J Radiat Oncol Biol Phys 2004;59(1):146–51. DOI: 10.1016/j.ijrobp.2003.09.088Ataseven B., Lederer B., Blohmer J.U. et al. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 2015;22(4):1118–27. DOI: 10.1245/s10434-014-4122-7Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378(9804):1707–16. DOI: 10.1016/S0140-6736(11)61629-2Poortmans P.M.P., Weltens C., Fortpied C. et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. Lancet Oncol 2020;21(12):1602–10. DOI: 10.1016/S1470-2045(20)30472-1Offersen B.V., Boersma L.J., Kirkove C. et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 2015;114(1):3–10. DOI: 10.1016/j.radonc.2014.11.030Murray Brunt A., Haviland J.S., Wheatley D.A. et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet 2020;395(10237):1613–26. DOI: 10.1016/S0140-6736(20)30932-6Smith B.D., Bellon J.R., Blitzblau R. et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol 2018;8(3):145–52. DOI: 10.1016/j.prro.2018.01.012Formenti S.C., Gidea-Addeo D., Goldberg J.D. et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007;25(16):2236–42. DOI: 10.1200/JCO.2006.09.1041Van la Parra R.F.D., Kuerer H.M. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res 2016;18(1):28. DOI: 10.1186/s13058-016-0684-6